XML 37 R61.htm IDEA: XBRL DOCUMENT
v2.4.1.9

10. Other Income and Expenses (Details) (USD $) | 12 Months Ended | 3 Months Ended
--- | --- | ---
Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2012
Gain (Loss) on Disposition of Property Plant Equipment | $ (400,000)us-gaap_GainLossOnSaleOfPropertyPlantEquipment | $ (500,000)us-gaap_GainLossOnSaleOfPropertyPlantEquipment | $ 4,800,000 us-gaap_GainLossOnSaleOfPropertyPlantEquipment |
Interest and investment income | (13,500,000)us-gaap_InvestmentIncomeInterestAndDividend | (13,400,000)us-gaap_InvestmentIncomeInterestAndDividend | (11,400,000)us-gaap_InvestmentIncomeInterestAndDividend |
Net realized losses (gains) on investments | 0 us-gaap_RealizedInvestmentGainsLosses | 300,000 us-gaap_RealizedInvestmentGainsLosses | (8,700,000)us-gaap_RealizedInvestmentGainsLosses |
Other-than-temporary impairment losses on investments | 400,000 us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet | 300,000 us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet | 1,000,000 us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet |
Gain (Loss) on Disposition of Assets | (400,000)us-gaap_GainLossOnDispositionOfAssets1 | (500,000)us-gaap_GainLossOnDispositionOfAssets1 | 3,800,000 us-gaap_GainLossOnDispositionOfAssets1 |
Miscellaneous Other (Income) Expense Items, Net | (300,000)bio_MiscellaneousOtherIncomeExpenseItems | (500,000)bio_MiscellaneousOtherIncomeExpenseItems | 1,000,000 bio_MiscellaneousOtherIncomeExpenseItems |
Other (income) expense, net | 13,009,000 us-gaap_OtherNonoperatingIncomeExpense | 12,766,000 us-gaap_OtherNonoperatingIncomeExpense | 21,883,000 us-gaap_OtherNonoperatingIncomeExpense |
Goodwill, Written off Related to Sale of Business Unit | 0 us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit | 0 us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit | 1,000,000 us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit |
Clinical Diagnostics [Member] |  |  |  |
Consideration for sale of building |  |  |  | 6,400,000 bio_ConsiderationForSaleOfBuilding / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember
Gain (Loss) on Disposition of Property Plant Equipment |  |  |  | 4,300,000 us-gaap_GainLossOnSaleOfPropertyPlantEquipment / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember
Goodwill, Written off Related to Sale of Business Unit |  |  |  | $ 1,000,000 us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit / us-gaap_StatementBusinessSegmentsAxis = bio_ClinicalDiagnosticsMember

X
- Definition Consideration for sale of building + References No definition available. + Details
Name: | bio_ConsiderationForSaleOfBuilding
Namespace Prefix: | bio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Miscellaneous Other (Income) Expense Items + References No definition available. + Details
Name: | bio_MiscellaneousOtherIncomeExpenseItems
Namespace Prefix: | bio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2443-110228 + Details
Name: | us-gaap_GainLossOnDispositionOfAssets1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 + Details
Name: | us-gaap_GainLossOnSaleOfPropertyPlantEquipment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 + Details
Name: | us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7(a),(b)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 7 -Subparagraph a, b -Article 5 + Details
Name: | us-gaap_InvestmentIncomeInterestAndDividend
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.9) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_OtherNonoperatingIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of other than temporary impairment (OTTI) losses on equity securities, OTTI related to credit losses on debt securities, and OTTI losses on debt securities when the entity intends to sell the securities or it is more likely than not that the entity will be required to sell the securities before recovery of its amortized cost basis. Additionally, this item includes OTTI losses recognized during the period on investments accounted for under the cost method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 8B -URI http://asc.fasb.org/extlink&oid=27724398&loc=SL6284393-111563 + Details
Name: | us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net realized gains or losses on investments during the period, not including gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.3(a)) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 325 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6485959&loc=d3e22529-158502 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 3 -Subparagraph a -Article 7 + Details
Name: | us-gaap_RealizedInvestmentGainsLosses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bio_ClinicalDiagnosticsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |